Different Spectrum of Vascular Complications After Angio-Seal Deployment or Manual Compression

Author(s): 

Alessandro Lupi, MD1, Andrea Rognoni, MD1, Gioel Gabrio Secco, MD2, Maurizio Lazzero, MD1,
Laura Plebani, MD1, Giuseppe Cossa, MD3, Danilo Reale, MD3, Federico Nardi, MD4, Mara Sansa, MD1, Angelo S. Bongo, MD1

References

  1. Michalis LK, Rees MR, Patsouras D, et al. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angio-Seal, VasoSeal and Duett). Cardiovasc Intervent Radiol. 2002;25(5):423-429.
  2. Kapadia SR, Raymond R, Knopf W, et al. The 6 Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol. 2001;87(6):789-791.
  3. Eggebrecht H, Haude M, von Birgelen C, et al. Early clinical experience with the 6 French Angio-Seal device: immediate closure of femoral puncture sites after diagnostic and interventional coronary procedures. Catheter Cardiovasc Interv. 2001;53(4):437-442.
  4. Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002;40(1):78-83.
  5. Kim HY, Choo SW, Roh HG, et al. Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab, or thrombolytics during percutaneous endovascular procedures. Korean J Radiol. 2006;7(1):35-40.
  6. Cura FA, Kapadia SR, L’Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol. 2000;86(7):780-782.
  7. Chevalier B, Lancelin B, Koning R, et al; HEMOSTASE trial investigators. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv. 2003;58(3):285-291.
  8. Van Den Broek T, Liqui Lung PF, Suttorp MJ, Eefting FD, Schipper ME, Vink A. Vascular occlusion as a late complication of the Angio-Seal closure device. A review of literature. Minerva Cardioangiol. 2007;55(6):815-819.
  9. Mehta SK, Frutkin AD. Correspondence to article: closure of the femoral artery after cardiac catheterization — a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv. 2008;72(4):586.
  10. Patel MR, Jneid H, Derdeyn CP, et al. Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation. 2010;122(18):1882-1893.
  11. Marso SP, Amin AP, House JA, et al. National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303(21):2156-2164.
  12. Dauerman HL, Rao SV, Resnic FS, Applegate RJ. Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol. 2011;58(1):1-10.
  13. Amin FR, Yousufuddin M, Stables R, et al. Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the Angio-Seal device vs the Femostop device. Int J Cardiol. 2000;76(2-3):235-240.
  14. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001;38(3):638-641.
  15. Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291(3):350-357.

 

  1. Martin JL, Pratsos A, Magargee E, et al. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv. 2008;71(1):1-5.
  2. Veasey RA, Large JK, Silberbauer J, et al. A randomised controlled trial comparing StarClose and Angio-Seal vascular closure devices in a district general hospital — the SCOAST study. Int J Clin Pract. 2008;62(6):912-918.
  3. Deuling JH, Vermeulen RP, Anthonio RA, et al. Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv. 2008;71(4):518-523.
  4. Rastan A, Sixt S, Schwarzwälder U, et al. VIPER-2: a prospective, randomized single-center comparison of 2 different closure devices with a hemostatic wound dressing for closure of femoral artery access sites. J Endovasc Ther. 2008;15(1):83-90.
  5. Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44(6):1200-1209.
  6. Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol. 2004;16(5):243-246.
  7. Bangalore S, Arora N, Resnic FS. Vascular closure device failure: frequency and implications: a propensity-matched analysis. Circ Cardiovasc Interv. 2009;2(6):549-556.
  8. Park Y, Roh HG, Choo SW, et al. Prospective comparison of collagen plug (Angio-Seal) and suture-mediated (the Closer S) closure devices at femoral access sites. Korean J Radiol. 2005;6(4):248-255.
  9. Abando A, Hood D, Weaver F, Katz S. The use of the Angio-Seal device for femoral artery closure. J Vasc Surg. 2004;40(2):287-290.
  10. Upponi SS, Ganeshan AG, Warakaulle DR, et al. Angio-Seal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures — a randomized controlled trial. Eur J Radiol. 2007;61(2):332-334.
  11. Hermanides RS, Ottervanger JP, Dambrink JH, et al. Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison. J Invasive Cardiol. 2010;22(12):562-566.
  12. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: The Twenty-Sixth Annual SAS Users Group International Conference. Cary, NC: SAS Institute, 2004;214-226.
  13. Black PE. Greedy algorithm. In: Black PE, ed. Dictionary of Algorithms and Data Structures [online]. Gaithersburg, MD: US National Institute of Standards and Technology; February 2, 2005. http://www. itl.nist.gov/div897/sqg/dads/HTML/greedyalgo.html. 
  14. Lupi A, Lazzero M, Plebani L, Sansa M, Bongo AS. Safety and efficacy of the new Angio-Seal Evolution closure device: a single-center experience. J Invasive Cardiol. 2011;23(4):150-155.
  15. Behan MW, Large JK, Patel NR, Lloyd GW, Sulke AN. A randomised controlled trial comparing the routine use of an Angio-Seal STS device strategy with conventional femoral haemostasis methods in a district general hospital. Int J Clin Pract. 2007;61(3):367-372.

 

  1. Assali AR, Sdringola S, Moustapha A, et al. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv. 2003;58(1):1-5.
  2. Resnic FS, Arora N, Matheny M, Reynolds MR. A cost-minimization analysis of the Angio-Seal vascular closure device following percutaneous coronary intervention. Am J Cardiol. 2007;99(6):766-770.
  3. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757-763.

____________________________________________

From 1Hospital Cardiology, “Maggiore della Carità” Hospital, Novara, Italy, 2Division of Cardiology, University of Eastern Piedmont, “Maggiore della Carità” Hospital, Novara, Italy, 3Division of Cardiology, “S. Andrea” Hospital, Vercelli, Italy, and 4Division of Cardiology, “Castelli” Hospital, Verbania, Italy.
Disclosure: The authors have completed and returned the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors report no conflicts of interest regarding the content herein.
Manuscript submitted August 29, 2011, provisional acceptance given September 27, final version accepted December 20, 2011.
Address for correspondence: Alessandro Lupi, MD, Ospedale Maggiore della Carità, Cardiologia 2, Cso Mazzini 18, 28100, Novara, Italy. Email: lupialessandro1@tin.it

Bookmark/Search this post with
image description image description Other Original Contribution Articles




  


  
Post new comment


  



 
 




 
 




 
 



  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
More information about formatting options





Image CAPTCHA

 
 
 
Enter the characters shown in the image.